Evidence map›Paper›PMID 31699817›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Genetic LAMP2 deficiency accelerates the age-associated formation of basal laminar deposits in the retina.

Shoji Notomi, Kenji Ishihara, Nikolaos E Efstathiou, Jong-Jer Lee, Toshio Hisatomi, Takashi Tachibana, Eleni K Konstantinou, Takashi Ueta, Yusuke Murakami, Daniel E Maidana and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Exploiting autophagy and related pathways: pioneering new horizons in cataract therapy.Apoptosis : an international journal on programmed cell death · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 7 countries.

Shoji NotomiAngiogenesis Laboratory, Ophthalmology Department, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114.ORCID 0000-0002-7935-4244
Kenji IshiharaAngiogenesis Laboratory, Ophthalmology Department, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114.
Nikolaos E EfstathiouAngiogenesis Laboratory, Ophthalmology Department, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114.ORCID 0000-0002-6635-0391
Jong-Jer LeeAngiogenesis Laboratory, Ophthalmology Department, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114.
Toshio HisatomiDepartment of Ophthalmology, Kyushu University, Fukuoka 812-8582, Japan.
Takashi TachibanaDepartment of Ophthalmology, Kyushu University, Fukuoka 812-8582, Japan.ORCID 0000-0001-5004-6312
Eleni K KonstantinouAngiogenesis Laboratory, Ophthalmology Department, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114.
Takashi UetaAngiogenesis Laboratory, Ophthalmology Department, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114.
Yusuke MurakamiDepartment of Ophthalmology, Kyushu University, Fukuoka 812-8582, Japan.
Daniel E MaidanaAngiogenesis Laboratory, Ophthalmology Department, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114.ORCID 0000-0002-3447-4074
Yasuhiro IkedaDepartment of Ophthalmology, Kyushu University, Fukuoka 812-8582, Japan.
Shinji KumeDepartment of Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan.
Hiroto TerasakiDepartment of Ophthalmology, Kagoshima University, Kagoshima 890-8520, Japan.
Shozo SonodaDepartment of Ophthalmology, Kagoshima University, Kagoshima 890-8520, Japan.
Judith BlanzDepartment of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611.
Lucy YoungAngiogenesis Laboratory, Ophthalmology Department, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114.
Taiji SakamotoDepartment of Ophthalmology, Kagoshima University, Kagoshima 890-8520, Japan.
Koh-Hei SonodaDepartment of Ophthalmology, Kyushu University, Fukuoka 812-8582, Japan.
Paul SaftigInstitute of Biochemistry, Kiel University, Kiel D-24098, Germany.
Tatsuro IshibashiDepartment of Ophthalmology, Kyushu University, Fukuoka 812-8582, Japan.
Joan W MillerAngiogenesis Laboratory, Ophthalmology Department, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114.ORCID 0000-0003-2046-3996
Guido KroemerMetabolism, Cancer & Immunity Laboratory, INSERM U1138, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris 75006, France; kroemer@orange.fr vavvas@meei.harvard.edu.
Demetrios G VavvasAngiogenesis Laboratory, Ophthalmology Department, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114; kroemer@orange.fr vavvas@meei.harvard.edu.ORCID 0000-0002-8622-6478
Massachusetts Eye and Ear Infirmary · USKyushu University · JPKagoshima University · JPChristian-Albrechts-Universität zu Kiel · DEKarolinska University Hospital · SENorthwestern University · USShiga University of Medical Science · JP

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Patricia Ann D'Amore · 1985 to 2026
$25.5M
Necroptosis, neuroprotection and axonal regeneration in retina ganglion cell injuryR01EY025362 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI VAVVAS, DEMETRIOS · 2015 to 2018
$1.5M
Necroptosis and Neuroprotection in AMDR21EY023079 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI VAVVAS, DEMETRIOS · 2013 to 2014
$404k
NEI NIH HHS P30 EY003790NEI NIH HHS R01 EY025362NEI NIH HHS R21 EY023079
6 · The paper itself

Abstract

The early stages of age-related macular degeneration (AMD) are characterized by the accumulation of basal laminar deposits (BLamDs). The mechanism for BLamDs accumulating between the retinal pigment epithelium (RPE) and its basal lamina remains elusive. Here we examined the role in AMD of lysosome-associated membrane protein-2 (LAMP2), a glycoprotein that plays a critical role in lysosomal biogenesis and maturation of autophagosomes/phagosomes. LAMP2 was preferentially expressed by RPE cells, and its expression declined with age. Deletion of the

Indexed as

AgingAnimalsBasement MembraneBruch MembraneExocytosisHumansLysosomal-Associated Membrane Protein 2LysosomesMacular DegenerationMiceMice, KnockoutPhagocytosisRetinaRetinal Pigment EpitheliumLAMP2 protein, humanLysosomal-Associated Membrane Protein 2agingLAMP2lysosomeretinal degeneration

Identifiers

PMID31699817
PMCPMC6876195
OpenAlexW2988705775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.